In 1972, Dr. John Anthony Morris reported his research findings on the influenza vaccine to his superiors at the FDA. A distinguished doctor and government researcher, Dr. Morris had been comissioned 13 years earlier to scientifically justify the FDA’s plans to widely expand the flu vaccination program.
To his expectant audience, however, his results were thoroughly disappointing. Dr. Morris reported that the flu shot provided no measurable net benefit, in part because the injected product failed to stimulate antibody production in the lungs, thus allowing for viral replication in this sensitive area.
It was later realized that the lack of benefit also derives from the flu shot’s ability to increase vulnerability to viruses not covered in the shot, including unmatched strains of flu and different respiratory viruses dangerous in their own right.
Dr. Morris’ finding of no net benefit of the influenza vaccine has been repeatedly verified with contemporary data, including a study by Simonsen et al. (2005) that found that the large increase in flu vaccination of the elderly between 1980 and 2001 failed to decrease flu season mortality, and a study in Britain which found that the vast increase in flu shot uptake by those who had just turned 65 (vs. those who were just a bit younger) provided no decline in hospitalizations or deaths.
Important data on flu-shot coverages & C0VID mortality:
https://homevaccineeducationnetwork.com/flu-vaccine-and-covid-19